62 min listen
Episode 87
FromBiotech Hangout
ratings:
Length:
58 minutes
Released:
Feb 2, 2024
Format:
Podcast episode
Description
On this week’s Biotech Hangout, hosts Brad Loncar, Tim Opler, Luba Greenwood and Brian Skorney discuss the latest industry news including 2 biotech IPOs from ArriVent Bio ($175M) and CG Oncology ($380M). They also discuss Sanofi buying Inhibrx ($2.2B), Kura Oncology’s private placement ($150M) and Gilead’s failed phase 3 study. The hosts cover class-wide black box warnings from the FDA, including Amgen’s Prolia, plus Eli Lilly’s investigational gene therapy for hearing loss data, HPV vaccine study in Scotland and The House Ways and Means Committee approves restoration of R&D tax credit. *This episode aired on January 26, 2024
Released:
Feb 2, 2024
Format:
Podcast episode
Titles in the series (72)
Pre-ASCO Discussion: Perspectives on Emerging Oncology Treatments by Biotech Hangout